Trump says will sign executive order aimed at lowering medication costs
How did your country report this? Share your view in the comments.
Introduction:
The news topic “Trump says will sign executive order aimed at lowering medication costs” has drawn international attention, with various media outlets providing diverse insights, historical context, political stances, and on-the-ground developments. Below is a curated overview of how different countries and media organizations have covered this topic recently.
Quick Summary:
- President Donald Trump announced on Sunday that he plans to sign what he called the “most consequential executive order” in U.S. history. Trump said the executive order, set to be signed at 9 a.m. Monday, will implement a “Most Favored Nations’ policy requiring pharmaceutical companies to charge no more than the lowest price they offer for the same drug in any other country. This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals. These are the stocks that are most likely to be hit by this announcement when markets open on Monday, given their sizable exposure to Medicare, especially being classified as Part B. The prices for which are directly managed by the Centers for Medicare & Medicaid Services (CMS)
- US President Donald Trump announced on Sunday that he will sign an executive order to reduce prescription drug prices by aligning them with the lower rates paid by other high-income countries. Trump said the order, which he plans to sign Monday morning, would implement a ‘most favoured nation’ pricing policy. The Pharmaceutical Research and Manufacturers of America, the top US lobbying group for drugmakers, has voiced strong opposition to the proposal. During his first term, a similar proposal was blocked by a court. The executive order is expected to target the Medicare health insurance programme and may go beyond the drugs already slated for price negotiations under former President Joe Biden’s Inflation Reduction Act. That law enabled Medicare to negotiate prices for 10 high-cost drugs, with those rates set to take effect next year and additional drugs to follow in 2025.
Country-by-Country Breakdown:
Trump’s New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)
President Donald Trump announced on Sunday that he plans to sign what he called the “most consequential executive order” in U.S. history. Trump said the executive order, set to be signed at 9 a.m. Monday, will implement a “Most Favored Nations’ policy requiring pharmaceutical companies to charge no more than the lowest price they offer for the same drug in any other country. This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals. These are the stocks that are most likely to be hit by this announcement when markets open on Monday, given their sizable exposure to Medicare, especially being classified as Part B. The prices for which are directly managed by the Centers for Medicare & Medicaid Services (CMS) Read full article
Trump to Sign Executive Order Slashing Drug Prices to Match International Rates
US President Donald Trump announced on Sunday that he will sign an executive order to reduce prescription drug prices by aligning them with the lower rates paid by other high-income countries. Trump said the order, which he plans to sign Monday morning, would implement a ‘most favoured nation’ pricing policy. The Pharmaceutical Research and Manufacturers of America, the top US lobbying group for drugmakers, has voiced strong opposition to the proposal. During his first term, a similar proposal was blocked by a court. The executive order is expected to target the Medicare health insurance programme and may go beyond the drugs already slated for price negotiations under former President Joe Biden’s Inflation Reduction Act. That law enabled Medicare to negotiate prices for 10 high-cost drugs, with those rates set to take effect next year and additional drugs to follow in 2025. Read full article
Trump Signs Executive Order to Lower U.S. Medicine Prices – Major Impact on Healthcare Costs
President Donald Trump is poised to take action today by signing an executive order aimed at reducing the rising cost of medicines in the U.S. This measure comes as part of Trump’s ongoing efforts to alleviate the financial strain on American citizens, particularly the elderly. The focus of the order will be on medications administered in doctor’s offices, including injectables and infusions used in the treatment of diseases like cancer. Some experts argue that Trump’s claim of saving “trillions of dollars” might be an overestimate. However, even modest reductions could have a significant impact on Americans struggling with high healthcare costs. The signing of today’s executive order is a direct response to the public outcry over high medicine prices, aiming to bring relief to families across the nation. Read full article
Trump: New Executive Order Will Save ‘Trillions’ in Drug Costs
President Trump says he’ll sign an executive order aimed at lowering drug prices. The order would tie certain Medicare drug prices to the lowest price paid by other nations. The proposal focuses on drugs covered by Medicare Part B, not prescriptions filled at pharmacies. The move faces staunch opposition from the drug industry, which argues the change would undercut innovation and allow foreign countries to dictate US drug prices, among other things. It could save the government money, but the “TRILLIONS OF DOLLARS” in savings Trump claimed in his post may be an overestimate. It’s the latest in a series of attempts to lower drug prices by the White House and Congress. It was blocked by the courts and later rescinded during the Biden administration. Read full article
Trump to sign executive order aimed at lowering medication costs
US President Donald Trump says he’ll sign an executive order on Monday that could lower the cost of some medications. The order will direct the Department of Health and Human Services to tie what Medicare pays for medications administrated in a doctor’s office to the lowest price paid by other countries. The proposal would likely only impact certain drugs covered by Medicare and given in an office — think infusions that treat cancer, and other injectables. But it could potentially bring significant savings to the government, although the “TRILLIONS of DOLLARS” Trump boasted about in his post may be an exaggeration.“Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,” he wrote. Read full article
Global Perspectives Summary:
Global media portray this story through varied cultural, economic, and political filters. While some focus on geopolitical ramifications, others highlight local impacts and human stories. Some nations frame the story around diplomatic tensions and international relations, while others examine domestic implications, public sentiment, or humanitarian concerns. This diversity of coverage reflects how national perspectives, media freedom, and journalistic priorities influence what the public learns about global events.
How did your country report this? Share your view in the comments.
Sources:
- Trump’s New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket – Amgen (NASDAQ:AMGN), Bristol-Myers Squibb (NYSE:BMY)
- Trump to Sign Executive Order Slashing Drug Prices to Match International Rates
- Trump Signs Executive Order to Lower U.S. Medicine Prices – Major Impact on Healthcare Costs
- Trump: New Executive Order Will Save ‘Trillions’ in Drug Costs
- Trump to sign executive order aimed at lowering medication costs
Source: https://www.france24.com/en/americas/20250512-trump-says-will-sign-executive-order-aimed-at-lowering-medication-costs